The rapid development of small RNA and molecular biology research in the past 20 years
has enabled scientists to discover many new miRNAs that are proven to play essential roles …

Leukemia is a cancer that starts in blood stem cells in the bone marrow. Today, the proper
diagnosis and prognosis of leukemia are essential in mitigating the morbidity and mortality …

Background Hematological disorders are heterogeneous conditions ranging from malignant
to non-malignant disorders. Hematological malignancies comprise a collection of …

The proto-oncogenic transcription factor c-MYC plays a pivotal role in the development of
tumorigenesis, cellular proliferation, and the control of cell death. Its expression is frequently …

Pyrethroid insecticides have been broadly used as pest control in agriculture and residential
spaces, exerting high effectiveness of insecticidal property and relatively low toxicity to …

Abstract Acute Lymphoblastic Leukemia (ALL) is one of most frequent malignancy detected
in children, accounting for three quarters of all leukemia occurrences in children. Toll-Like …

Acute lymphoblastic leukemia (ALL) is an aggressive neoplasm derived from B and/or T cell
lineage (B-ALL; T-ALL). For the first time, this study describes, cytogenetically, the karyotypic …

Background: Acute myeloid leukemia (AML) is a common malignant disorder of the bone
marrow, accounting for 23.1% of total leukemia cases globally in 2017. This study aimed to …

Introduction and aims: Leukemia is a heterogeneous group of hematological disorders that
is made up of several diverse and biologically distinct subgroups. Leukemia is the eleventh …

Introduction: Continuous research for new effective drugs to treat cancer has improved our
understanding on the mechanism of action of these drugs and paved new potential for their …